Lindbrook Capital’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $746K | Buy |
1,177
+26
| +2% | +$16.5K | 0.07% | 166 |
|
|
2024
Q4 | $820K | Buy |
1,151
+6
| +0.5% | +$4.27K | 0.07% | 156 |
|
|
2024
Q3 | $1.2M | Sell |
1,145
-14
| -1% | -$14.7K | 0.11% | 125 |
|
|
2024
Q2 | $1.22M | Buy |
1,159
+40
| +4% | +$42K | 0.11% | 114 |
|
|
2024
Q1 | $1.08M | Buy |
1,119
+15
| +1% | +$14.4K | 0.1% | 128 |
|
|
2023
Q4 | $970K | Buy |
1,104
+74
| +7% | +$65K | 0.1% | 127 |
|
|
2023
Q3 | $848K | Buy |
1,030
+37
| +4% | +$30.5K | 0.09% | 121 |
|
|
2023
Q2 | $714K | Sell |
993
-48
| -5% | -$34.5K | 0.08% | 149 |
|
|
2023
Q1 | $855K | Buy |
1,041
+79
| +8% | +$64.9K | 0.1% | 124 |
|
|
2022
Q4 | $694K | Buy |
962
+34
| +4% | +$24.5K | 0.09% | 147 |
|
|
2022
Q3 | $639K | Buy |
928
+34
| +4% | +$23.4K | 0.11% | 112 |
|
|
2022
Q2 | $528K | Sell |
894
-17
| -2% | -$10K | 0.09% | 144 |
|
|
2022
Q1 | $636K | Buy |
911
+13
| +1% | +$9.08K | 0.1% | 133 |
|
|
2021
Q4 | $567K | Sell |
898
-1
| -0.1% | -$631 | 0.09% | 144 |
|
|
2021
Q3 | $544K | Buy |
899
+8
| +0.9% | +$4.84K | 0.14% | 61 |
|
|
2021
Q2 | $498K | Buy |
891
+51
| +6% | +$28.5K | 0.11% | 80 |
|
|
2021
Q1 | $397K | Sell |
840
-39
| -4% | -$18.4K | 0.09% | 92 |
|
|
2020
Q4 | $425K | Buy |
879
+51
| +6% | +$24.7K | 0.1% | 79 |
|
|
2020
Q3 | $463K | Sell |
828
-45
| -5% | -$25.2K | 0.13% | 65 |
|
|
2020
Q2 | $544K | Buy |
873
+11
| +1% | +$6.86K | 0.16% | 48 |
|
|
2020
Q1 | $421K | Sell |
862
-3
| -0.3% | -$1.47K | 0.16% | 51 |
|
|
2019
Q4 | $325K | Buy |
865
+5
| +0.6% | +$1.88K | 0.11% | 88 |
|
|
2019
Q3 | $239K | Buy |
860
+68
| +9% | +$18.9K | 0.09% | 109 |
|
|
2019
Q2 | $247K | Sell |
792
-48
| -6% | -$15K | 0.1% | 106 |
|
|
2019
Q1 | $344K | Hold |
840
| – | – | 0.14% | 74 |
|
|
2018
Q4 | $313K | Buy |
+840
| New | +$313K | 0.15% | 65 |
|